Should You Buy Nabriva Therapeutics PLC - ADR (NBRV) Stock Thursday?

Thursday, March 09, 2023 01:23 PM | InvestorsObserver Analysts

Mentioned in this article

Nabriva Therapeutics PLC - ADR (NBRV) stock is lower by -85.89% over the last 12 months, and the average rating from Wall Street analysts is a Sell. InvestorsObserver’s proprietary ranking system, gives NBRV stock a score of 23 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 10. NBRV's rank also includes a short-term technical score of 59.
NBRV has an Overall Score of 23. Find out what this means to you and get the rest of the rankings on NBRV!
See Full NBRV Report

What's Happening with NBRV Stock Today

Nabriva Therapeutics PLC - ADR (NBRV) stock has risen 0.64% while the S&P 500 is lower by -0.38% as of 12:32 PM on Thursday, Mar 9. NBRV is higher by $0.01 from the previous closing price of $1.57 on volume of 2,287 shares. Over the past year the S&P 500 has fallen -7.04% while NBRV is lower by -85.89%. NBRV lost -$19.49 per share in the over the last 12 months. Click Here to get the full Stock Report for Nabriva Therapeutics PLC - ADR stock.

Share this article:

Related Articles